Allakos Inc.

ALLK:NASDAQ

Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Allakos is a clinical stage biotechnology company developing antibodies that target immunomodulatory receptors present on immune effector cells involved in allergic, inflammatory and proliferative diseases.